UBU5:XETRA:XETRA-UBS (Irl) plc - MSCI USA Value UCITS USD A-dis (EUR)

ETF | Others |

Last Closing

USD 110.28

Change

+0.44 (+0.40)%

Market Cap

USD 0.63B

Volume

5.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.24 (+0.48%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.56%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.11 (+0.39%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.16 (+0.57%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.17 (+0.68%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.38 (+0.84%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+1.36 (+0.97%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.29 (+0.57%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.60 (+0.27%)

USD 80.38B

ETFs Containing UBU5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.92% 79% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.92% 79% B- 78% C+
Trailing 12 Months  
Capital Gain 29.54% 81% B- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.54% 81% B- 80% B-
Trailing 5 Years  
Capital Gain 49.88% 73% C 73% C
Dividend Return 8.60% 50% F 38% F
Total Return 58.48% 76% C+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain 11.26% 72% C 71% C-
Dividend Return 11.26% 72% C 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.14% 42% F 52% F
Risk Adjusted Return 79.61% 75% C 79% B-
Market Capitalization 0.63B 69% C- 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.